Candel Therapeutics (CADL) Earnings Date & Reports

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CADL is expected to report earnings to fall 6.35% to -37 cents per share on May 08

Candel Therapeutics CADL Stock Earnings Reports

Q1'25

Est.

$-0.37

Q4'24

Missed

by $0.10

Q4'23

Missed

by $0.20

Q3'23

Missed

by $0.10

Q2'23

Missed

by $0.03

The last earnings report on March 13 showed earnings per share of -40 cents, missing the estimate of -30 cents. With 534.50K shares outstanding, the current market capitalization sits at 215.87M.

View a ticker or compare two or three

Compare

CADL